NovoCure Ltd. (NVCR) PT Lowered to $95 at Truist Securities
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $17.44 +2.89%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Truist Securities analyst Gregory Fraser lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $95.00 (from $102.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- SM Prime Holdings, Inc (SMPH:PM) (SPHXF) PT Lowered to PHP21 at JPMorgan
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
